Symphony Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
Symphony Asset Management's TMO Position: Q1 2020 in Review
Symphony Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 3,714 shares — an estimated $1.21M sold.
Symphony Asset Management first reported a position in TMO in Q2 2013 and held it in 15 quarters. The position peaked at $4.05M in Q3 2017. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.
- Symphony Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
- Symphony Asset Management sold 3,714 Thermo Fisher Scientific shares in Q1 2020, an estimated $1.21M.
- Symphony Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 15 quarters.
- Symphony Asset Management's Thermo Fisher Scientific position peaked at $4.05M in Q3 2017.
- 1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.
Based on Symphony Asset Management's 13F filing for Q1 2020, filed 12 May 2020.